Cheon-Hyoung Park

Title: Cheon-Hyoung Park: Innovator in Antibacterial Agents

Introduction

Cheon-Hyoung Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His innovative work focuses on compounds that can effectively combat Gram-negative bacterial infections.

Latest Patents

Cheon-Hyoung Park holds a patent for "Tetrahydropyridine derivatives and their use as antibacterial agents." This patent describes a novel tetrahydropyridine derivative compound, its stereoisomers, and pharmaceutically acceptable salts. The patent outlines methods for preparing these compounds and their application in inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC). The compounds are designed for treating Gram-negative bacterial infections and can be used in therapeutic medicaments and pharmaceutical compositions aimed at preventing or treating such infections. His work demonstrates the potential for these compounds to exhibit excellent effects in treating bacterial infections.

Career Highlights

Cheon-Hyoung Park is associated with Dong-a St Co., Ltd., where he continues to advance his research and development efforts. His dedication to innovation in the pharmaceutical field has positioned him as a key figure in the fight against bacterial infections.

Collaborations

Cheon-Hyoung Park has collaborated with notable colleagues, including Sun-Ho Choi and Weon-Bin Im. These partnerships have contributed to the advancement of his research and the successful development of new antibacterial agents.

Conclusion

Cheon-Hyoung Park's contributions to the field of antibacterial agents highlight his innovative spirit and commitment to improving healthcare. His work in developing tetrahydropyridine derivatives showcases the potential for new treatments against bacterial infections.